C.-J. Soussy

851 total citations
29 papers, 664 citations indexed

About

C.-J. Soussy is a scholar working on Pharmacology, Molecular Medicine and Molecular Biology. According to data from OpenAlex, C.-J. Soussy has authored 29 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 12 papers in Molecular Medicine and 9 papers in Molecular Biology. Recurrent topics in C.-J. Soussy's work include Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). C.-J. Soussy is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). C.-J. Soussy collaborates with scholars based in France, Morocco and United Kingdom. C.-J. Soussy's co-authors include Christine Lascols, J Duval, Jacques Tankovic, Emmanuelle Cambau, Daniel Dhumeaux, Jean‐Philippe Miguet, Philippe Mavier, Rafik Bachoual, F. Mory and F. Le Goffic and has published in prestigious journals such as Gastroenterology, Antimicrobial Agents and Chemotherapy and Psychological Medicine.

In The Last Decade

C.-J. Soussy

27 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.-J. Soussy France 15 272 223 162 146 127 29 664
Kathrine Dornbusch Sweden 14 370 1.4× 242 1.1× 144 0.9× 160 1.1× 71 0.6× 41 754
B Slocombe United Kingdom 13 264 1.0× 314 1.4× 252 1.6× 322 2.2× 56 0.4× 31 870
Alicia Rossi Argentina 13 226 0.8× 195 0.9× 86 0.5× 147 1.0× 63 0.5× 16 652
C. C. Sanders United States 15 488 1.8× 116 0.5× 304 1.9× 159 1.1× 52 0.4× 29 810
A. Vatopoulos Greece 15 341 1.3× 209 0.9× 84 0.5× 141 1.0× 80 0.6× 31 643
Donna J. Blazevic United States 17 177 0.7× 245 1.1× 117 0.7× 249 1.7× 112 0.9× 62 942
H. Chardón France 10 129 0.5× 165 0.7× 68 0.4× 107 0.7× 67 0.5× 42 413
Lilian Pumbwe United States 18 478 1.8× 307 1.4× 141 0.9× 365 2.5× 297 2.3× 24 1.0k
A Gouby France 14 420 1.5× 189 0.8× 165 1.0× 251 1.7× 37 0.3× 25 950
John Tomayko United States 14 234 0.9× 327 1.5× 142 0.9× 152 1.0× 43 0.3× 18 763

Countries citing papers authored by C.-J. Soussy

Since Specialization
Citations

This map shows the geographic impact of C.-J. Soussy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.-J. Soussy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.-J. Soussy more than expected).

Fields of papers citing papers by C.-J. Soussy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.-J. Soussy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.-J. Soussy. The network helps show where C.-J. Soussy may publish in the future.

Co-authorship network of co-authors of C.-J. Soussy

This figure shows the co-authorship network connecting the top 25 collaborators of C.-J. Soussy. A scholar is included among the top collaborators of C.-J. Soussy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.-J. Soussy. C.-J. Soussy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fisher, Helen L., Bruno Étain, A. Méary, et al.. (2008). Self-reported childhood trauma correlates with schizotypal measures in schizophrenia but not bipolar pedigrees. Psychological Medicine. 39(3). 365–370. 17 indexed citations
2.
Cesaro, Arturo, et al.. (2008). Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes. Journal of Antimicrobial Chemotherapy. 61(5). 1007–1015. 54 indexed citations
3.
Lesprit, Philippe, Christine Lascols, Erick Denamur, et al.. (2006). In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid. Journal of Antimicrobial Chemotherapy. 58(5). 1054–1057. 27 indexed citations
4.
Cambau, Emmanuelle, Christine Lascols, Wladimir Sougakoff, et al.. (2006). Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002–2005. Clinical Microbiology and Infection. 12(10). 1013–1020. 50 indexed citations
5.
Leclercq, Roland, et al.. (2003). Activité in vitro de la pristinamycine vis-à-vis des staphylocoques isolés dans les hôpitaux français en 1999–2000. Pathologie Biologie. 51(7). 400–404. 15 indexed citations
6.
Bachoual, Rafik, et al.. (2001). Single or Double Mutational Alterations of GyrA Associated with Fluoroquinolone Resistance in Campylobacter jejuni and Campylobacter coli. Microbial Drug Resistance. 7(3). 257–261. 80 indexed citations
7.
Felmingham, D., D F Brown, & C.-J. Soussy. (1998). European glycopeptide susceptibility survey of Gram-positive bacteria for 1995. Diagnostic Microbiology and Infectious Disease. 31(4). 563–571. 19 indexed citations
8.
Tankovic, Jacques, et al.. (1996). Quinolone Resistance Mutations in the gyrA Gene of Clinical Isolates of Salmonella. Microbial Drug Resistance. 2(3). 299–302. 30 indexed citations
9.
Hooper, David C., et al.. (1995). Sequential mutations of gyr A in Escherichia coli associated with quinolone therapy. Journal of Antimicrobial Chemotherapy. 36(6). 1055–1059. 14 indexed citations
10.
11.
Soussy, C.-J., M Kitzis, C. Chanal, G. Carret, & E Derlot. (1991). [In vitro antibacterial activity of piperacillin-tazobactam combination on hospital isolates and regression curve].. PubMed. 39(5). 367–73. 2 indexed citations
12.
Soussy, C.-J., Marie Chanal, & Marie-Dominique Kitzis. (1990). The in-vitro activity of cefodizime: a review. Journal of Antimicrobial Chemotherapy. 26(suppl C). 13–21. 6 indexed citations
13.
Deforges, Lionel, C.-J. Soussy, & J Duval. (1984). [Effect of the amoxicillin-gentamicin combination in the presence of clavulanic acid on 8 strains of amoxicillin-resistant bacteria].. PubMed. 32(5 Pt 2). 496–500.
14.
Soussy, C.-J., et al.. (1980). Cefotaxime concentration in the bile and wall of the gallbladder. Journal of Antimicrobial Chemotherapy. 6(suppl A). 125–130. 18 indexed citations
15.
Tillement, J P, et al.. (1980). Erythromycin pharmacokinetics in man.. PubMed. 8 Suppl 2. 9–14. 10 indexed citations
16.
Romano, P. Martin, et al.. (1979). Bilan bactériologique du service de réanimation chirurgicale et traumatologique de l'Hôpital Henri Mondor.. 20. 1 indexed citations
17.
Goffic, F. Le, et al.. (1977). 2″- O -Phosphorylation of Gentamicin Components by a Staphylococcus aureus Strain Carrying a Plasmid. Antimicrobial Agents and Chemotherapy. 12(1). 26–30. 38 indexed citations
18.
Goffic, François Le, et al.. (1977). Plasmid-mediated pristinamycin resistance. PAC IIA: A new enzyme which modifies pristinamycin IIA.. The Journal of Antibiotics. 30(8). 665–669. 32 indexed citations
19.
Miguet, Jean‐Philippe, Philippe Mavier, C.-J. Soussy, & Daniel Dhumeaux. (1977). Induction of Hepatic Microsomal Enzymes after Brief Administration of Rifampicin in Man. Gastroenterology. 72(5). 924–926. 63 indexed citations
20.
Goffic, F. Le, Pilar Baca, C.-J. Soussy, A. Dublanchet, & J Duval. (1976). [ANT(4')I: a new aminoglycoside nucleotidyltransferase found in "staphylococcus aureus" (author's transl)].. PubMed. 127(3). 391–9. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathrine Dornbusch Breakdown of academic impact, for papers by B Slocombe Breakdown of academic impact, for papers by Alicia Rossi Breakdown of academic impact, for papers by C. C. Sanders Breakdown of academic impact, for papers by A. Vatopoulos Breakdown of academic impact, for papers by Donna J. Blazevic Breakdown of academic impact, for papers by H. Chardón Breakdown of academic impact, for papers by Lilian Pumbwe Breakdown of academic impact, for papers by A Gouby Breakdown of academic impact, for papers by John Tomayko
Rankless by CCL
2026